Leiomyoma (Uterine Fibroids)

2

Review clinical trials related to Leiomyoma (Uterine Fibroids). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Artificial Intelligence Into Ultrasound Diagnostics in Reproductive Medicine

The goal of this observational study is to develop and validate artificial intelligence (AI)-based algorithms that support ultrasound diagnosis of endometriosis, adenomyosis, myometrial masses, uterine malformations, and impaired endometrial receptivity in women aged 18-45 years. The main questions it aims to answer are: Can AI algorithms, applied to standardized transvaginal ultrasound images, accurately detect and classify endometriosis and adenomyosis in real time during routine examination? Can AI-based ultrasound assessment predict the histological dignity of myometrial masses, and the likelihood of successful assisted reproduction (AR/IVF) outcome from endometrial features? Participants attending the Department of Obstetrics and Gynecology, Semmelweis University, with clinical suspicion of endometriosis or adenomyosis, a confirmed myometrial mass scheduled for surgery, a suspected uterine anomaly, or scheduled IVF treatment, will undergo standardized transvaginal ultrasound examination (following the IDEA, MUSA, and IETA protocols) alongside collection of clinical, questionnaire, and, where surgery is performed, histopathological data. Imaging and clinical data will be used to build a database supporting the development and validation of the AI algorithms.

Participants needed: 1,600
Trial details
Age: 18-45Biological sex: FemaleType: ObservationalSponsor: Semmelweis UniversityUpdated: Sep 18, 2026Locations: 1Duration: 3 Years
Eligibility criteria

Women aged 18-45 years with clinical suspicion of endometriosis or adenomyosis,... [+4]

TVUS is not technically feasible. [+7]

Status: Recruiting

The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function

This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day complications.

Participants needed: 60
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Erkan GolUpdated: Mar 3, 2026Locations: 1
Eligibility criteria

Women aged ≥18 years [+4]

Gynecologic malignancy [+3]